- Fierce Pharma Biopharma News Insights
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance
- Health Pharma News | Latest Healthcare Stories | Reuters
U S President Donald Trump and nine major pharmaceutical companies on Friday announced deals that will slash the prices of their medicines for the government's Medicaid program and for cash
- Biotech and Pharma Industry News | BioPharma Dive
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more
- Pharmaceuticals sector - Financial Times
Comprehensive coverage of the pharmaceuticals industry The latest news and developments from the world's leading drug companies, including Pfizer, Johnson Johnson, AstraZeneca and more
- Pharma, Biotech and Generics Industry News | The Pharmaletter
Up to date news for the pharmaceutical and biotechnology industries - The Pharma Letter
- Pharma Sector News | PharmaVoice
Big Pharma needs new products to replenish pipelines and has plenty of money in the coffers, but looming uncertainties could stymie dealmaking again With great power comes great responsibility, and Eli Lilly is employing financial success and technical know-how to give smaller biotechs a leg up
- News | PharmExec
In today’s Pharmaceutical Executive Daily, Eli Lilly reports positive topline Phase III results for retatrutide, the FDA expands Amgen’s Uplizna label into generalized myasthenia gravis subtypes, and a new analysis explores whether pharmaceutical manufacturing is truly moving back onshore
- Citeline News Insights | Expert Analysis in Pharma, Biotech, Medtech
In-depth global journalism and expert analysis of the pharma, biotech, medtech, and consumer health industries We go beyond the headlines to deliver news with context and impact
|